Vivos Therapeutics, Inc. (VVOS)
0.0569
-0.02
(-25.13%)
USD |
NASDAQ |
Nov 19, 16:00
0.0567
0.00 (0.00%)
After-Hours: 20:00
Vivos Therapeutics Net Income (Quarterly) : -1.971M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -1.971M |
| June 30, 2026 | -5.523M |
| March 31, 2026 | -7.751M |
| December 31, 2025 | -6.954M |
| September 30, 2025 | -5.40M |
| June 30, 2025 | -5.013M |
| March 31, 2025 | -3.864M |
| December 31, 2024 | -2.827M |
| September 30, 2024 | -2.616M |
| June 30, 2024 | -1.93M |
| March 31, 2024 | -3.763M |
| December 31, 2023 | -4.259M |
| September 30, 2023 | -2.093M |
| June 30, 2023 | -5.528M |
| Date | Value |
|---|---|
| March 31, 2023 | -1.703M |
| December 31, 2022 | -6.089M |
| September 30, 2022 | -5.434M |
| June 30, 2022 | -6.992M |
| March 31, 2022 | -5.331M |
| December 31, 2021 | -7.393M |
| September 30, 2021 | -5.453M |
| June 30, 2021 | -4.042M |
| March 31, 2021 | -3.399M |
| December 31, 2020 | -9.847M |
| September 30, 2020 | -1.813M |
| March 31, 2020 | -2.581M |
| December 31, 2019 | -2.627M |
| September 30, 2019 | -3.092M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Hinge Health, Inc. | 57.40M |
| Exlites Holdings International, Inc. | -0.0039M |
| Xcelerate, Inc. | -0.0302M |
| Abbott Laboratories | 920.00M |
| AngioDynamics, Inc. | -7.097M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 6.414M |
| Total Expenses (Quarterly) | 8.359M |
| EPS Diluted (Quarterly) | -0.0733 |
| Enterprise Value | 11.72M |
| Gross Profit Margin (Quarterly) | 43.09% |
| Profit Margin (Quarterly) | -30.73% |
| Earnings Yield | -2.90K% |
| Normalized Earnings Yield | -2935.68 |